| Literature DB >> 30622487 |
Markus Gerber1, Alice Minghetti1, Johannes Beck2, Lukas Zahner1, Lars Donath3.
Abstract
Background: Sprint interval training (SIT) has become increasingly popular and is seen as a promising exercise strategy to increase fitness in healthy people. Nevertheless, some scholars doubt the appropriateness of a SIT training protocol for largely physically inactive populations. SIT might be too arduous, and therefore contribute to feelings of incompetence, failure, and lower self-esteem, which may undermine participants' exercise motivation. Therefore, we examined whether participation in 12 SIT sessions would lead to different changes in self-determined motivation, affective responses to exercise, cardiorespiratory fitness, physical activity, and depressive symptom severity compared to aerobic exercise training (CAT) in a sample of patients with major depressive disorders (MDD).Entities:
Keywords: affective response; exercise; fitness; major depressive disorder; motivation; physical activity; randomized controlled trial; sprint interval training
Year: 2018 PMID: 30622487 PMCID: PMC6308196 DOI: 10.3389/fpsyt.2018.00694
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1Participant flow chart.
Descriptive statistics and baseline differences.
| Age (years) | 36.4 (11.3) | 36.4 (12.4) | 36.5 (10.4) | −0.05 | 0.00 |
| Height (cm) | 169.1 (9.2) | 171.0 (9.5) | 167.1 (8.7) | 1.51 | 0.43 |
| Weight (kg) | 68.4 (14.7) | 67.7 (14.6) | 69.0 (15.2) | −0.30 | −0.09 |
| BMI (kg/m2) | 23.8 (4.0) | 23.0 (3.5) | 24.6 (4.4) | −1.44 | 0.40 |
| Systolic BP (mmHG) | 110.0 (14.5) | 109.9 (15.2) | 110.1 (13.9) | −0.03 | −0.01 |
| Diastolic BP (mmHG) | 74.6 (10.1) | 74.4 (10.6) | 75.0 (9.8) | −0.18 | 0.06 |
| Sex | 0.12 | −0.05 | |||
| Women | 39 (78) | 19 (76) | 20 (80) | ||
| Men | 11 (22) | 6 (24) | 5 (20) | ||
| Smoking status | 0.40 | 0.09 | |||
| Smoking | 14 (28) | 8 (32) | 6 (24) | ||
| Non-smoking | 36 (72) | 17 (68) | 19 (76) | ||
| Velafaxin (75, 175, 225 mg) | 7 (14) | 3 (12) | 4 (16) | ||
| Mirzapin (7.5, 15, 30 mg) | 11 (22) | 6 (24) | 5 (20) | ||
| Wellbutrin (150 mg) | 2 (4) | 1 (4) | 1 (4) | ||
| Trittico (25, 50, 100 mg) | 5 (10) | 3 (12) | 2 (8) | ||
| Escitalopram (10, 20 mg) | 11 (22) | 6 (24) | 5 (20) | ||
| Citalopram (20 mg) | 4 (8) | 1 (4) | 3 (12) | ||
| Fluoxetin (20, 40 mg) | 2 (4) | 0 (0) | 2 (8) | ||
| Paroxetin (20 mg) | 1 (2) | 1 (4) | 0 (0) | ||
| Cipralex (60 g) | 1 (2) | 1 (4) | 0 (0) | ||
| Seralin (50 mg) | 1 (2) | 0 (0) | 1 (4) | ||
| Quetiapin (25, 50, 150, 300 mg) | 4 (8) | 3 (12) | 1 (4) | ||
| Trimipramin (50 mg) | 1 (2) | 0 (0) | 1 (4) | ||
Data from metric variables expressed as means (M) and standard deviations (SD). Data from categorical variables expressed as frequencies (n) and percentage (%).BMI, body mass index; SIT, sprint interval training; CAT, continuous aerobic exercise training; SNRIs, Serotonin and norepinephrine reuptake inhibitors; SSRIs ,Selective Serotonin Reuptake Inhibitors.
Differences between participants assigned to SIT and CAT conditions across time.
| Intrinsic motivation | 2.4 (0.9) | 2.6 (0.8) | 2.7 (0.7) | 2.9 (0.7) | 7.7 | 0.13 | 1.9 | 0.04 | 0.0 | 0.00 |
| Identified motivation | 3.1 (0.8) | 3.3 (0.6) | 3.1 (0.7) | 3.3 (0.6) | 5.5 | 0.10 | 0.0 | 0.00 | 0.2 | 0.01 |
| Introjected motivation | 2.4 (0.7) | 2.4 (0.9) | 2.4 (0.8) | 2.5 (0.7) | 0.2 | 0.00 | 0.0 | 0.00 | 0.4 | 0.01 |
| Extrinsic motivation | 1.5 (0.6) | 1.5 (0.5) | 1.6 (0.7) | 1.5 (0.7) | 0.7 | 0.01 | 0.0 | 0.00 | 0.1 | 0.00 |
| Self-determination index | 2.4 (2.9) | 3.1 (2.6) | 3.0 (2.5) | 3.7 (3.1) | 6.9 | 0.13 | 0.5 | 0.01 | 0.00 | 0.00 |
| Cardiorespiratory fitness (VO2max) | 33.1 (8.6) | 33.9 (9.1) | 31.6 (6.3) | 32.9 (6.6) | 6.3 | 0.13 | 0.3 | 0.01 | 0.4 | 0.01 |
| Perceived fitness | 3.6 (2.1) | 5.1 (1.9) | 4.1 (2.0) | 5.4 (1.8) | 45.0 | 0.48 | 0.5 | 0.01 | 0.4 | 0.01 |
| MPA (min/week) | 48 (78) | 56 (58) | 28 (32) | 142 (155) | 11.4 | 0.19 | 3.0 | 0.06 | 8.8 | 0.16 |
| VPA (min/week) | 46 (84) | 75 (87) | 33 (45) | 102 (183) | 6.6 | 0.12 | 0.1 | 0.00 | 1.2 | 0.02 |
| MVPA (min/week) | 94 (141) | 130 (123) | 60 (65) | 244 (290) | 12.3 | 0.20 | 1.1 | 0.02 | 5.60 | 0.10 |
| Depressive symptoms | 31.8 (10.8) | 18.8 (12.7) | 35.2 (10.3) | 23.1 (11.4) | 109.8 | 0.70 | 1.6 | 0.03 | 0.2 | 0.00 |
Data expressed as means (M) and standard deviations (SD). MPA, moderate physical activity; VPA, vigorous physical activity; MVPA, moderate-to-vigorous physical activity.
< 0.05;
p < 0.01;
p < 0.001.
Figure 2Changes of affective valence during exercise (A) and after exercise (B) from the first to the last week of intervention, separately for SIT and CAT.
Figure 3Percentage of participants who meet vs. do not meet physical activity recommendations, separately for SIT and CAT, at baseline and post-intervention.